Fatty Liver: Why 1 in 3 Indian Adults Has It, and the One Thing That Reverses It

A 2022 meta-analysis pooling Indian studies put the prevalence of fatty liver at around 38 percent of adults. In some urban cohorts it passes half. It is found on ultrasounds ordered for other reasons, mentioned as an aside, and then ignored, because the liver enzymes were normal and nobody explained what it meant.

Left alone, most cases stay mild. A meaningful minority progress to inflammation, scarring and eventually cirrhosis, and the ones that do rarely announce themselves. Here is how to know which kind you have and what actually turns it around.

What fatty liver is, and what it is now called

Fatty liver means more than 5 percent of the liver's weight is fat. In 2023 the condition was renamed from non-alcoholic fatty liver disease to metabolic dysfunction-associated steatotic liver disease, or MASLD, to reflect what drives it: insulin resistance, waist fat and the metabolic pattern that comes with them.

It sits on a spectrum:

1. Simple steatosis. Fat in the liver, no inflammation. The majority stay here.
2. MASH. Fat plus inflammation and liver cell injury. This is the stage that scars.
3. Fibrosis, graded F0 to F4. Scar tissue accumulating. F2 and above is where risk climbs.
4. Cirrhosis, F4. Extensive scarring, with the risk of liver failure and liver cancer.

The fibrosis stage, not the amount of fat, predicts what happens to you. Two people with the same ultrasound can have completely different outlooks.

Why India in particular

South Asians store fat around the organs and in the liver at a lower body weight than Europeans, and carry less muscle for the same BMI. Around one in five Indian cases occurs in people with a normal BMI, the so-called lean MASLD. A diet built on refined carbohydrate and fried food, low physical activity, and a genetic variant called PNPLA3 that is common in the region all push the same way.

That is why waist circumference, not weight, is the number to watch. Above 90 cm in men or 80 cm in women, the odds of fatty liver rise sharply regardless of what the scale says.

How it is found and staged

• Ultrasound — detects fat once it exceeds roughly 20 to 30 percent of the liver; limitation: misses mild cases and cannot stage fibrosis
• FIB-4 score — estimates fibrosis risk from age, AST, ALT and platelets; limitation: a screen, not a diagnosis
• FibroScan — measures fat (CAP score) and stiffness (kPa) in one scan; limitation: less accurate at high BMI
• MRI-PDFF — a precise fat percentage; limitation: cost and availability
• Liver biopsy — definitive staging; limitation: invasive, and rarely needed now

The FIB-4 score is the one everybody should know. It uses four numbers you probably already have. Below 1.3 makes advanced fibrosis unlikely. Above 2.67 makes it likely enough to need a specialist. Between the two, a FibroScan settles it. The bloodwork analyzer calculates FIB-4 from a standard liver panel and blood count and flags when the combination suggests scanning, which is the step most people never get told about.

The bloodwork picture

The trap is that liver enzymes are often normal. A person can have significant fat and early fibrosis with an ALT inside the range.

When enzymes do rise, the pattern is usually ALT slightly higher than AST, and GGT raised alongside. The rest of the panel tells the metabolic story: raised triglycerides, low HDL, raised fasting insulin or HbA1c, and often a raised ferritin as a marker of inflammation rather than iron overload.

Fatty liver rarely comes alone, and the blood test selector adds a platelet count and GGT when the reason for testing is a fatty liver finding, so that FIB-4 can be calculated.

What reverses it

Weight loss, specifically loss of waist fat. Nothing else comes close, and the evidence is unusually clear about how much. A 2015 study by Vilar-Gomez and colleagues followed patients with MASH through a year of diet and exercise:

• 5 percent of bodyweight lost reduced liver fat
• 7 to 10 percent resolved the inflammation in most patients
• 10 percent or more regressed fibrosis in the majority

For an 85 kg man, that is 6 to 9 kg. Not extreme, and within reach of a sensible deficit over four to six months.

What speeds it up:

• Resistance training reduces liver fat independently of weight loss, because muscle takes up glucose that would otherwise be turned into liver fat.
• Cutting sugar and fructose. Sugar-sweetened drinks and juice are converted to liver fat more directly than any other food.
• Alcohol, less or none. Even moderate intake adds to metabolic fat.
• Coffee. Two to three cups a day is consistently associated with less fibrosis in observational studies.
• A diet built on protein, vegetables, legumes and whole grains, with refined carbohydrate reduced at dinner in particular.

The drugs

Two medications now carry approval for MASH with significant fibrosis, and neither is for simple fatty liver:

• Resmetirom, a thyroid hormone receptor agonist targeted at the liver, was approved in the US in March 2024 for MASH with F2 to F3 fibrosis.
• Semaglutide was approved in the US in August 2025 for the same group. In the ESSENCE trial, 63 percent of patients on semaglutide had their MASH resolve at 72 weeks compared with 34 percent on placebo.

Tirzepatide and retatrutide have shown similar or larger effects on liver fat in earlier-phase work. Pioglitazone and vitamin E at 800 IU a day have older evidence in specific groups and are used under specialist care. None of these replaces weight loss. All of them work better alongside it.

Supplements with a rationale, and the limits

No supplement reverses fatty liver on its own. A few have mechanisms worth knowing:

• TUDCA, a bile acid, improves bile flow and has clinical use in some cholestatic liver conditions.
• NAC replenishes glutathione, the liver's main antioxidant.
• Curcumin has reduced liver fat modestly in small trials.
• Milk thistle has a long history and weak trial evidence.
• Berberine improves insulin sensitivity and has lowered liver fat in small studies.

If you want TUDCA, NAC and curcumin in one product with each dose stated rather than hidden in a blend, God of Supps makes one, Invictus Liver. It is support for a liver under load, alongside waist fat loss, not a substitute for it. Anyone who tells you a capsule reverses fatty liver without changing anything else is selling the capsule.

For enhanced athletes

Oral anabolic steroids modified at the 17-alpha position stress the liver directly, and stacking that on top of existing fatty liver compounds the risk. A FIB-4 and a FibroScan before any oral compound is basic due diligence.

Growth hormone, interestingly, reduces liver fat, which is one reason GH-deficient adults develop fatty liver. That does not make it a treatment. It makes it one more reason to know your liver status before you start anything.

When to see a doctor

A FIB-4 above 1.3, a platelet count below 150, fatty liver alongside type 2 diabetes, or any symptom such as fatigue, right upper abdominal discomfort, yellowing or easy bruising. Those need a hepatologist, and the sooner fibrosis is staged, the more of it is reversible.

The short version

Fatty liver affects more than a third of Indian adults, including lean ones, and normal enzymes do not rule it out. Calculate FIB-4, scan if it is above 1.3, and treat it as a waist fat problem. Losing 7 to 10 percent of bodyweight resolves most cases. Resmetirom and semaglutide exist for MASH with fibrosis, and supplements are support at most.

Related tools

• Bloodwork analyzer: calculates FIB-4 and reads liver enzymes with the metabolic markers around them
• Blood test selector: adds platelets and GGT when fatty liver is the reason for testing
• Cardiac risk score: fatty liver and heart risk travel together, this reads the second half

Related guides

• The Insulin Resistance Reversal System — a free guide on the insulin resistance and waist fat that drive fatty liver, with the bloodwork and the step-by-step fix

Frequently asked questions

Can fatty liver be reversed?

Yes, in most cases. Losing 5 percent of bodyweight reduces liver fat, 7 to 10 percent resolves inflammation in most patients, and 10 percent or more regresses fibrosis in the majority.

What is the FIB-4 score?

A fibrosis risk score calculated from age, AST, ALT and platelet count. Below 1.3 makes advanced fibrosis unlikely, above 2.67 makes it likely, and values in between call for a FibroScan.

Can you have fatty liver with normal liver enzymes?

Yes, and it is common. ALT and AST can sit inside the reference range with significant liver fat and even early fibrosis present. Enzymes alone do not rule it out.

Why is fatty liver so common in India?

South Asians store more fat in the liver and around the organs at a lower body weight, carry less muscle for the same BMI, eat a carbohydrate-heavy diet, and commonly carry the PNPLA3 gene variant. About one in five Indian cases occurs at a normal BMI.

Which medicines treat fatty liver?

Resmetirom, approved in 2024, and semaglutide, approved in 2025, both for MASH with significant fibrosis. Neither is approved for simple fatty liver, and both work alongside weight loss rather than instead of it.

Does milk thistle cure fatty liver?

No. Milk thistle has weak trial evidence. TUDCA, NAC and curcumin have clearer mechanisms, but no supplement reverses fatty liver without waist fat loss.

This article is educational and is not medical advice. See the medical disclaimer.